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Streptococcus pneumoniae (the pneumococcus) is an opportunistic pathogen that
colonizes the human nasopharynx asymptomatically. Invasive pneumococcal disease
develops following bacterial aspiration into the lungs. Pneumococci within the
nasopharynx exist as biofilms, a growth phenotype characterized by surface attachment,
encasement within an extracellular matrix, and antimicrobial resistance. Experimental
evidence indicates that biofilm pneumococci are attenuated vs. their planktonic
counterpart. Biofilm pneumococci failed to cause invasive disease in experimentally
challenged mice and in vitro were shown to be non-invasive despite being hyper-adhesive.
This attenuated phenotype corresponds with observations that biofilm pneumococci elicit
significantly less cytokine and chemokine production from host cells than their planktonic
counterparts. Microarray and proteomic studies show that pneumococci within biofilms
have decreased metabolism, less capsular polysaccharide, and reduced production of
the pore-forming toxin pneumolysin. Biofilm pneumococci are predominately in the
transparent phenotype, which has elevated cell wall phosphorylcholine, an adhesin subject
to C-reactive protein mediated opsonization. Herein, we review these changes in virulence,
interpret their impact on colonization and transmission, and discuss the notion that
non-invasive biofilms are principal lifestyle of S. pneumoniae.
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INTRODUCTION
Streptococcus pneumoniae (the pneumococcus) is a leading cause
of community-acquired pneumonia (CAP), sepsis, and meningi-
tis throughout the world despite the existence of multiple effective
vaccines (Bennett et al., 2014). This Gram-positive, encapsulated
bacterium asymptomatically colonizes the human nasopharynx
where carriage can last for months (Gray et al., 1980). In sus-
ceptible individuals, usually the very young and elderly, aspira-
tion of pneumococci can lead to pneumonia and subsequently
invasive pneumococcal disease (IPD). At any given time approx-
imately 40% of children and 15% of adults are colonized (Crook
et al., 2004; Huang et al., 2009). Annual global IPD burden is
roughly 14.5 million cases resulting in 800,000 deaths in chil-
dren under the age of 5 and a case fatality rate surpassing 20%
in the elderly (O’Brien et al., 2009; Heron, 2012; Naucler et al.,
2013).
S. pneumoniae in sputum and blood samples from indi-
viduals with IPD are primarily in the form of lancet-shaped
diplococci; the same morphology observed when grown plank-
tonically in media. Growth as diplococci or short chains is now
recognized to help S. pneumoniae evade stochastic alternative
pathway mediated complement deposition and opsonophago-
cytosis (Dalia and Weiser, 2011). Within the past 15 years it
has become evident that the pneumococcus also forms biofilms
in vivo during nasopharyngeal colonization (Figure 1) and oti-
tis media (Hoa et al., 2009; Reid et al., 2009). Biofilms are
aggregates of surfaced attached bacteria encased within an extra-
cellular matrix (ECM). The ECM, which in vivo is composed
of host factors, polysaccharides, and extracellular DNA, is now
understood to protect bacteria from the host immune system
and desiccation (Moscoso et al., 2006); the latter being important
during pneumococcal fomite transmission (Walsh and Camilli,
2011). Importantly, biofilm pneumococci have been shown to be
decisively less virulent than their planktonic counterparts. This
review focuses on how S. pneumoniae modulates its virulence
during biofilm formation and why this may promote long-term,
asymptomatic colonization. We also discuss the increasingly evi-
dent role biofilms play during pneumococcal transmission on
fomites.
BIOFILM PNEUMOCOCCI ARE AVIRULENT
Given the importance of biofilms in recalcitrant infections and
for S. pneumoniae in the middle ear during otitis media (Reid
et al., 2009; Chauhan et al., 2014), initial studies examining pneu-
mococcal biofilms sought to associate the ability to form biofilms
with enhanced virulence (Munoz-Elias et al., 2008; Lizcano et al.,
2010). However, the ability to form biofilms in vitro could not
be linked to the anatomical site from which a clinical isolate
was obtained (i.e., nasopharynx of an asymptomatic carrier or
blood from individual with IPD), nor the ability of the isolate to
cause bacteremia in an infectious mouse model (Hall-Stoodley
et al., 2008; Lizcano et al., 2010). Importantly, these and other
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FIGURE 1 | Pneumococcal biofilms form in the nasopharynx. (A)
Scanning electron microscopy image of S. pneumoniae biofilms formed on
the nasal septum of a mouse. Mice were experimentally colonized 7 days
prior. Biofilms are the non-contiguous aggregates on the left. (B)
S. pneumoniae biofilm aggregate in nasopharyngeal lavage fluid. Sample was
collected from mouse 14 days after experimental colonization. Pneumococci
were stained with crystal violet and visualized with a light microscope at
400X. Image credit: Krystle Blanchette.
studies have shown that in vitro biofilm formation was most
enhanced for mutants that lacked capsular polysaccharide (CPS)
(Moscoso et al., 2006). CPS mutants are avirulent due to their
inability to prevent opsonophagocytosis (Hyams et al., 2010).
Thus, the fact that unencapsulated mutants form more robust
biofilms suggested a direct disconnect between pneumococcal
biofilm formation and its propensity for invasive disease.
To directly test if pneumococci within biofilms were viru-
lent, Sanchez et al. intratracheally challenged mice with equal
colony forming units (CFU) of a virulent serotype 4 isolate grown
to exponential (mid-logarithmic) phase in media or as a 3-day
biofilm in a continuous flow-through reactor. They observed that
only mice infected with planktonic pneumococci progressed to
bacteremia while most of those challenged with biofilm pneu-
mococci had negative blood cultures (Figure 2A) (Sanchez et al.,
2011b). Studies by Blanchette-Cain et al. showed that pneumo-
cocci grown as a biofilm were hyper-adhesive yet uninvasive
when tested in vitro on Detroit-562 pharyngeal epithelial cells
(Figure 2B) (Blanchette-Cain et al., 2013). Marks et al. had sim-
ilar results and showed that pneumococci grown as biofilms on
fixed and live NCI-H292 bronchial epithelial cells neither invaded
nor were internalized. Of note, Marks et al. showed that pneumo-
cocci recently dispersed from a biofilm due to an inflammatory
signal, such as viral infection, were hyper-virulent with substan-
tially greater capacity to cause invasive disease in mice than either
biofilm pneumococci or pneumococci grown for a sustained
period planktonically (Marks et al., 2013).Why recently dispersed
pneumococci are more virulent than their sustained planktonic
counterparts is not immediately clear, albeit two possibilities are
that these bacteria carry biofilm ECM components that enhance
their adhesive capacity, and major changes in gene expression
profiles (Pettigrew et al., 2014). This observation helps to explain
why viral infection is an established risk factor for the develop-
ment of pneumococcal pneumonia (Brundage, 2006; McCullers,
2006).
REDUCED CAPSULAR POLYSACCHARIDE DURING BIOFILM
GROWTH
CPS is the principal virulence determinant for S. pneumoniae
and exists in >90 identified serotypes (Bennett et al., 2014). In
addition to resisting opsonophagocytosis (Melin et al., 2010), the
negative or neutral charge of CPS plays an important role in
helping the pneumococcus evade entrapment in mucus (Nelson
et al., 2007). The necessity of CPS for IPD is exhibited by the
fact that all invasive strains of S. pneumoniae are encapsulated
whereas unencapsulated pneumococci are infrequent and usually
only associated with topical eye infection (Barker et al., 1999).
Multiple investigators have reported an inhibitory role for CPS
during in vitro biofilm formation with capsule deficient mutants
forming substantially more robust biofilms than their encap-
sulated parent strain (Moscoso et al., 2006; Qin et al., 2013).
Allergucci and Sauer showed that biofilms formed by a serotype 3
isolate were in large part composed of spontaneous mutants defi-
cient in CPS related genes (Allegrucci and Sauer, 2007). Marks
et al. have added evidence that this may occur in vivo by showing
that unencapsulated pneumococci form more robust biofilms on
the surface of epithelial cell monolayers (Marks et al., 2012). In
fact, the presence of a capsule was shown to inhibit unencapsu-
lated pneumococci from forming robust biofilms inmixed in vitro
cultures (Domenech et al., 2009). Yet, CPS production is required
for efficient in vivo colonization (Shainheit et al., 2014), indi-
cating that during colonization the pneumococcus must strike
a balance between CPS hindrance of biofilm formation and
resistance to host defense.
Gene expression analyses using qRT-PCR and microarrays
have shown that genes within the CPS operon were downreg-
ulated during in vitro biofilm formation vs. planktonic growth
(Oggioni et al., 2006; Sanchez et al., 2011b). Moreover, the
amount of capsule detected and the enzymes responsible for
CPS production were substantially lower for biofilm vs. plank-
tonic grown pneumococci as detected by ELISA andMALDI-TOF
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FIGURE 2 | Biofilm pneumococci are less virulent and elicit a weaker
immune response than their planktonic counterparts. (A) Bacterial titers
in the lungs and blood of BALB/c mice challenged intratracheally with 105 CFU
of planktonic or biofilm derived S. pneumoniae (each square = individual
mouse; n = 6–8). From: Sanchez et al. (2011b). (B) Percentage of planktonic
and biofilm derived S. pneumoniae that attached and invaded Detroit-562
pharyngeal cells in vitro. Percentages were calculated from the total inoculum.
(C) Cytokine levels in nasopharyngeal lavage fluid (NALF) of colonized mice.
Mice were challenged with wild type (WT) and PsrP-deficient (psrP−)
S. pneumoniae and NALF collected 7 days later. Note that psrP− does not
form biofilms during colonization (n = 5). Panels (B,C) from: Blanchette-Cain
et al. (2013). Asterisks denote a statistically significant difference (P < 0.05).
(Sanchez et al., 2011a,b). In agreement with dynamic changes in
CPS production, pneumococci reduce capsule thickness once in
contact with epithelial cells (Hammerschmidt et al., 2005). This
is supported by microarray gene analysis of cells in contact with
respiratory epithelial cells in vitro (Orihuela et al., 2004b). Thus,
biofilm pneumococci reduce levels of CPS making them more
susceptible to phagocytosis following aspiration.
PHASE VARIATION
S. pneumoniae oscillates between an opaque phase variant that
produces high levels of CPS and low levels of cell wall teichoic
acid, and a transparent phase variant with low CPS and high
cell wall teichoic acid (Weiser et al., 1994). The basis for phase
variation is now understood to be epigenetic, with alternate
methylation patterns on genes (Manso et al., 2014). Due to neg-
ative selection for the transparent phase by phagocytes, opaque
variants predominate in the blood (Kim and Weiser, 1998). In
contrast, the transparent phenotype is better able to adhere to
cells and thus predominates in the nasopharynx (Weiser et al.,
1994). Of note, Sanchez et al. have shown that in vitro biofilms are
primarily composed of the transparent variant, despite the seed
cultures used to initiate the biofilm beingmostly opaque (Sanchez
et al., 2011b).
In its transition from opaque to transparent, the pneumococ-
cus loses virulence potential while enhancing its ability to adhere
to host cells. As discussed, loss or a reduction in CPS enhances
susceptibility to opsonophagocytosis yet is required for the expo-
sure of surface adhesins that mediate bacterial attachment to host
cells (Ring et al., 1998). Critically, cell invasion occurs for plank-
tonic but not biofilm pneumococci (Blanchette-Cain et al., 2013).
The increased amount of teichoic acid carried by the transparent
variant also makes it subject to recognition by C-reactive pro-
tein (CRP), resulting in activation of complement (Kim et al.,
1999). However, phosphorylcholine residues present on teichoic
acid allow the pneumococcus to bind to the host ligand platelet-
activating factor (PAFr) receptor on host cells (Cundell et al.,
1995).
Despite loss of capsule and increased exposure of teichoic
acid, pneumococci in biofilms are resistant to opsonophagocy-
tosis (Yuste et al., 2007). One reason for this includes that CRP
binding to phosphorylcholine is competed with by members of
the choline-binding protein family (Mukerji et al., 2012), such as
the adhesin Choline-binding protein A (CbpA) which is upreg-
ulated during transparent phase growth as well as in biofilms
(Sanchez et al., 2011b). CbpA is also a key inhibitor of comple-
ment deposition through its binding to Factor H and complement
component C3 (Cheng et al., 2000; Dave et al., 2001). Another
choline-binding protein that plays a key role in complement inhi-
bition includes Pneumococcal surface protein A (PspA), which
prevents classical complement activation in a C1q dependent
manner (Tu et al., 1999; Yuste et al., 2007; Mukerji et al., 2012).
Importantly, the opaque variant has been suggested to play a
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critical role in the formation of the ECM (Trappetti et al., 2011).
Of note, gene expression studies for biofilms and transparent
pneumococci do not entirely overlap. Thus, phase variation is an
important aspect of pneumococcal biofilm formation but is not
entirely responsible for its phenotype.
DOWNREGULATION OF METABOLIC PROCESSES AND
MODULATED VIRULENCE GENE EXPRESSION
Antimicrobial resistance is one of the defining properties of
biofilms and has been extensively documented for biofilm pneu-
mococci, particularly in the context of recurring otitis media
(Stewart and Costerton, 2001; Hall-Stoodley et al., 2008). Why,
the ability of an isolate to form well-structured biofilms in vivo
was correlated with resistance to high concentrations of gen-
tamycin (Marks et al., 2012). Enhanced resistance to antimi-
crobials in biofilm pneumococci may be due to a decrease in
metabolic rate, which also confers resistance to antimicrobials
targeting cell wall, protein synthesis, and DNA replication. The
ECM also serves as an inhibitor or off-target for antimicro-
bials. This topic is extensively reviewed elsewhere (Domenech
et al., 2012). Once aspirated, a reduced metabolic rate would pre-
sumably impair the ability of biofilm pneumococci to respond
in a timely fashion to hostile host factors present in the lower
respiratory tract.
Along such lines, planktonic and biofilm S. pneumoniae are
now recognized to have distinct protein and gene expression pro-
files. Using qRT-PCR, Oggioni et al. showed that the gene expres-
sion profile of virulence-associated genes of different strains
isolated from the blood were more similar to that of planktonic
growth in broth, whereas the same strain isolated from the lungs,
brain, or nasopharynx of infected mice was more similar to that
of in vitro biofilms (Oggioni et al., 2006). Microarray analysis
of in vitro grown planktonic vs. biofilm pneumococci showed
that biofilm pneumococci downregulated genes involved in pro-
tein synthesis, energy production, metabolism, CPS production;
along with the virulence genes that encode the pneumococcal
pilus, which has been shown to be an invasin (Barocchi et al.,
2006), and the pore-forming toxin pneumolysin (Sanchez et al.,
2011b). Pneumolysin has been demonstrated to be required for
systemic bacteremia and host cell damage and inflammation
(Orihuela et al., 2004a; Mitchell and Dalziel, 2014), thus its down
regulation would most likely compromise virulence. Yet pneu-
molysin has also been shown to contribute toward in vitro biofilm
formation (Shak et al., 2013). Thus, and like that for CPS, pneu-
molysin production is most likely fine-tuned to strike a balance
with the host during colonization. In contrast, the genes encod-
ing the adhesins PsrP, PavA as well as the previously discussed
CbpA, were detected as being upregulated during biofilm growth
(Sanchez et al., 2011b; Qin et al., 2013). These proteins may play
a role in intra-species aggregation such as observed during in vivo
biofilms, either by binding to other pneumococci directly or
through bridging molecules such as fibronectin (Blanchette and
Orihuela, 2012). The, why biofilm pneumococci do not invade
cells remains unclear.
Mass spectroscopy (MS) based identification of proteins iso-
lated from biofilm and planktonic cell lysates confirm pro-
found differences between these two physiological growth states
(Allegrucci et al., 2006; Sanchez et al., 2011a). One impor-
tant caveat to this approach is that pneumococcal biofilms are
in part composed of dead pneumococci and proteomic studies
don’t distinguish between proteins from live bacteria or those
dead bacteria that have accumulated within the biofilm. When
alive, these dead bacteria may have had a substantially differ-
ent proteome. Nonetheless, and in agreement with microarray
studies, MS of biofilm and planktonic cell lysates by Sanchez
et al. found that the frequency of peptides corresponding to
enzymes involved in protein synthesis and processing, energy
metabolism, CPS production, and proteins involved in tran-
scription, regulation and DNA binding, as well as the virulence
determinants enolase, pyruvate oxidase (produces hydrogen per-
oxide), and pneumolysin were less frequent in biofilm lysates than
planktonic lysates (Sanchez et al., 2011a). The extent to which
major differences occur in the proteome is further highlighted
by the finding that antiserum from humans who recovered from
IPD robustly recognized proteins in planktonic cell lysates but
not biofilm cell lysates when tested by Western blot (Sanchez
et al., 2011a). This provides evidence that the in vivo antigen
protein profiles for colonization vs. invasive disease are consid-
erably different, and that the overall productions of factors that
mediate a response to a host or subvert the host response are
altered.
HOST RESPONSE TO BIOFILM PNEUMOCOCCI
Only recently have investigators begun to examine how the host
responds to biofilm pneumococci. Studies by Blanchette-Cain
et al. have shown that biofilm pneumococci elicit significantly less
Interleukin (IL)-6 and IL-8 from Detroit-562 pharyngeal epithe-
lial cells than planktonic cultures. Similarly, biofilm pneumococci
elicited less IL-6, IL-1β, and TNFα, from J774A.1macrophages. In
vivo, mutant pneumococci lacking the biofilm determinant PsrP,
and thus unable to form in vivo biofilms, elicited greater TNFα,
IL-6, IL-1β, and KC production in the nasopharynx of 7-day col-
onized mice vs. its parent strain (Figure 2C) (Blanchette-Cain
et al., 2013). This was credited to the reduced tissue invasive-
ness of biofilm pneumococci, but as indicated may also involve
reduced production of the toxin pneumolysin. Importantly,
pneumococci may also actively suppress the host response in a
way that has not yet been determined. For example studies have
shown that Group B Streptococcus interacts with Siglec-5 and this
dampens the host response (Carlin et al., 2009). Future studies
examining this possibility are warranted.
Given the fact that the majority of individuals are colonized
asymptomatically, we speculate that non-invasive pneumococci
within biofilms promote long-term colonization and transmis-
sion through less vigorous activation of the innate immune
response and therefore a delay in the onset of the adaptive
response and their clearance. Yet, direct evidence for this is
lacking with intranasal challenge of mice with PsrP-deficient or
other mutants that are biofilm deficient not resulting in reduced
bacterial titers in the nasopharynx when measured by CFU or
qRT-PCR (Blanchette-Cain et al., 2013). Thus, studies are war-
ranted to determine what the true physiological advantage of
this immunoquiescent phenotype actually is and if it impacts the
number of bacteria in the nasopharynx or long-term carriage.
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BIOFILMS AS SOURCE OF FOMITE TRANSMISSION AND
CONCLUSIONS
Multiple studies have shown that biofilm-derived pneumococci
are more resistant to desiccation than their planktonic coun-
terparts (Walsh and Camilli, 2011), with viable cells isolated
from fomites over a period ten times longer than planktonic
(Marks et al., 2014). Additionally, viable pneumococci have been
recovered from a variety of desiccated surfaces in a day care set-
ting: hands, books, and both hard and soft toys. Importantly,
desiccated pneumococci recovered from fomites still retain col-
onization capabilities in a murine model, even with a normal
inoculum (Walsh and Camilli, 2011; Marks et al., 2014). As
is shown in Figure 1B, the pneumococcal aggregates can be
sloughed from the nasopharynx and these aggregates most likely
are a vehicle for transmission, possibly providing the bacteria
with moisture and nutrients for an extended period outside the
body. We point out that dispersed bacteria, as shown by Marks
et al. (2013), are planktonic and may be a second vehicle for
transmission following an inflammatory episode such as virus
infection.
Most individuals carrying S. pneumoniae are colonized asymp-
tomatically, thus the biofilm state is the major form by which
the pneumococcus interacts with its host. Herein we have dis-
cussed how biofilm pneumococci are distinct from their plank-
tonic counterparts. Specifically, pneumococci downregulate CPS,
enhance expression of adhesins, shift toward the transparent phe-
notype, and lower the expression of metabolic processes and
key virulence determinants that elicit a robust host response.
Therefore, biofilm pneumococci seem to be exquisitely honed to
the colonization phenotype at the expense of the invasive phe-
notype. There are many questions that remain to be answered;
for example, direct evidence that the immunoquiescent pheno-
type confers a colonization advantage is lacking. This may be due
to limitations in the current model systems and/or our ability to
quantify bacteria in vivo. Additionally, does the pneumococcus
rely on dispersal of biofilm aggregates or the spread of highly inva-
sive biofilm dispersed planktonic pneumococci as the principle
method for transmission, or are both effective? Perhaps differ-
ent strains rely differently on these transmission methods. There
are also infections that seem to be a mix of biofilms and plank-
tonic bacteria, for example during otitis media. How these two
physiological states impact the course of disease is unclear and
warrants attention. In summary, a myriad of functional reasons
can and do exist for why biofilm pneumococci are less virulent.
A better understanding of the short-term survival and long-term
evolutionary advantages would substantially enhance our under-
standing of pneumococcal biology, and may permit us to develop
novel targets for bacterial clearance.
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